On 2025-05-14, Enliven Therapeutics, Inc. (ELVN) announced earnings per share of $-0.57 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.51.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.54 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.51 | $-0.57 |
| 2025-03-13 | 2024-12-31 | $-0.53 | $-0.46 |
| 2024-11-13 | 2024-09-30 | $-0.52 | $-0.48 |
| 2024-08-13 | 2024-06-30 | $-0.58 | $-0.41 |
| 2024-05-14 | 2024-03-31 | $-0.58 | $-0.54 |
| 2024-03-14 | 2023-12-31 | $-0.56 | $-0.47 |
| 2023-11-09 | 2023-09-30 | $-0.49 | $-0.51 |
| 2023-08-10 | 2023-06-30 | $-0.40 | $-0.41 |
| 2023-05-11 | 2023-03-31 | $-0.67 | $-0.80 |
| 2023-02-10 | 2022-12-31 | -- | $4.92 |
| 2022-10-25 | 2022-09-30 | -- | $-0.72 |
| 2022-08-03 | 2022-06-30 | $-2.24 | $-1.76 |
| 2022-05-06 | 2022-03-31 | $-2.28 | $-2.24 |
| 2022-03-15 | 2021-12-31 | $-3.16 | $-2.12 |
| 2021-11-09 | 2021-09-30 | $-3.64 | $-2.20 |
| 2021-08-06 | 2021-06-30 | $-3.08 | $-2.96 |
| 2021-05-11 | 2021-03-31 | $-3.36 | $-2.32 |
| 2021-03-05 | 2020-12-31 | $-3.36 | $-4.36 |
| 2020-11-05 | 2020-09-30 | $-3.32 | $-2.88 |
| 2020-08-14 | 2020-06-30 | $-2.44 | $-2.36 |
| 2020-05-07 | 2020-03-31 | $-2.96 | $-17.24 |